BioSpace News Archive

MYND Diagnostics Inc. Announces Participation in Approved Monash University (Australia) Government Funded $3 Million Clinical Trial

MYND Diagnostics Inc., a wholly-owned subsidiary of MYND Life Sciences (CSE: MYND) (OTC: MYNDF), is pleased to announce that the Company’s proprietary biomarker testing technology will be a pivotal component of a $3 million, Government of Australia funded clinical trial.

February 8, 2022

·

5 min read

BioCapital

American Diabetes Association Teams Up With Dr. Comfort To Take Next Step in Preventing and Managing Foot Complications

Every four minutes, an American loses a limb due to diabetes—a complication that could be preventable when given the right tools.

February 8, 2022

·

2 min read

Business

Samyang Biopharm USA Announces Appointment of Eun-Ju Ryu as New President

Samyang Biopharm USA, Inc. (https://us.samyangbiopharm.com) a global biotech subsidiary of the Samyang Holdings Corp. (https://samyangbiopharm.com/eng), announced today that Eun-Ju Ryu has been appointed President of Samyang Biopharm USA, end of Jan. 2022.

February 8, 2022

·

3 min read

Business

CHOC names new neurology medical director and Neuroscience Institute co-medical director

CHOC is thrilled to welcome Dr. John Crawford as its new Medical Director of Neurology and Co-Medical Director of the CHOC Neuroscience Institute.

February 8, 2022

·

2 min read

Deals

Nuvectis Pharma Announces Closing of $16,000,000 Upsized Initial Public Offering of Common Stock

Nuvectis Pharma, Inc. announced the closing of its previously announced upsized initial public offering of 3,200,000 shares of common stock at a public offering price of $5.00 per share, for gross proceeds of $16,000,000, before deducting underwriting discounts and offering expenses.

February 8, 2022

·

3 min read

Bio NC

Revibe Technologies Announces Clinical Development Updates for its Investigational FokusRx Prescription Digital Therapy for the Treatment of ADHD

Revibe technologies, a commercial-stage digital therapeutics company, announced today the positive results of their feasibility study examining the efficacy of FokusRx in school aged children with attention deficit hyperactivity disorder (ADHD).

February 8, 2022

·

5 min read

Business

Applied Cells Inc. Enters Collaborative Marketing Agreement with S2 Genomics Inc. to Provide a Powerful Tumor Biology Solution in Tissue Sample Preparation

Applied Cells today announced a joint marketing agreement with S2 Genomics to further the field of tumor biology.

February 8, 2022

·

2 min read

Lone Star Bio

McKesson Designated by CMS as 2022 Qualified Clinical Data Registry

For the sixth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry.

February 8, 2022

·

4 min read

Bio NC

Providers Rank Fujifilm “Best in KLAS” for Three Synapse® Enterprise Imaging Solutions

FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, has ranked #1 in KLAS Research’s 2022 ‘Best in KLAS’ report for Fujifilm’s Synapse VNA and Synapse Cardiology PACS in the United States, and Synapse Radiology PACS in Latin America.

February 8, 2022

·

5 min read

Pharm Country

Changing Lives, Delivering Value: Quoin Pharmaceuticals is Making the Balancing Act Look Easy

Biotechs count on an innovative pipeline and external collaborations for growth, scaling and fundraising.

February 8, 2022

·

7 min read